Andromeda Capital’s Exelon EXC Stock Holding History

Andromeda Capital’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-19,719	Closed	-$385K	–	119
2013 Q4	$385K	Buy	+19,719	New	+$397K	0.05%	95

Other funds holding EXC

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Andromeda Capital's EXC Position: Q1 2014 in Review

Andromeda Capital sold out of Exelon (EXC) in Q1 2014, closing a stake of 19,719 shares — an estimated $385K sold.

Andromeda Capital first reported a position in EXC in Q4 2013 and held it in 1 quarter. The position peaked at $385K in Q4 2013. 680 funds tracked by Wall St. Rank hold EXC as of Q1 2014.

Andromeda Capital reported no remaining Exelon position as of Q1 2014 after selling out during the quarter.
Andromeda Capital sold 19,719 Exelon shares in Q1 2014, an estimated $385K.
Andromeda Capital first reported a position in Exelon in Q4 2013 and held it in 1 quarter.
Andromeda Capital's Exelon position peaked at $385K in Q4 2013.
680 funds tracked by Wall St. Rank held Exelon as of Q1 2014.

Based on Andromeda Capital's 13F filing for Q1 2014, filed 15 May 2014.